JMP Securities Healthcare Conference to Be Held in New York
01 Oktober 2008 - 11:25PM
Business Wire
JMP Group Inc. (NYSE:JMP), an investment banking and alternative
asset management firm, announced today that its broker-dealer
subsidiary, JMP�Securities, will host the third annual JMP
Securities Healthcare Focus Conference at Le Parker Meridien in New
York on Monday and Tuesday, October 6 and 7, 2008. The two-day
conference will feature presentations by senior executives of
nearly 90 public and private companies in the biotechnology,
medical devices and healthcare services industries before an
audience of institutional investors and financial sponsors. For
additional details or to register to attend the event, visit
www.jmpsecurities.com/about/events.html or
www.twstevent.com/jmp.html. Companies scheduled to present as of
September 30, 2008; subject to change: A.D.A.M., Inc. ACADIA
Pharmaceuticals Inc. Acceleron Pharma, Inc. Achillion
Pharmaceuticals, Inc. Alexza Pharmaceuticals, Inc. Allos
Therapeutics, Inc. Allscripts Healthcare Solutions, Inc. Alnylam
Pharmaceuticals, Inc. American CareSource Holdings, Inc. Anadys
Pharmaceuticals, Inc. ARCA biopharma, Inc. Ardea Biosciences, Inc.
athenahealth Inc. AtriCure, Inc. AVEO Pharmaceuticals, Inc. AVI
BioPharma, Inc. BioCryst Pharmaceuticals, Inc. C. R. Bard, Inc.
Cadence Pharmaceuticals, Inc. Celera Corporation Celgene
Corporation Celleration, Inc. Cerus Corporation Chem Rx Corporation
Concert Pharmaceuticals, Inc. Corcept Therapeutics Incorporated
Cypress Bioscience, Inc. Cytokinetics, Incorporated DexCom, Inc.
DiagnoCure Inc. Dialysis Corporation of America Echo Therapeutics,
Inc. Eclipsys Corp. Enanta Pharmaceuticals, Inc. Endocare Inc.
Exelixis, Inc. EyeGate Pharmaceuticals, Inc. Genomic Health, Inc.
Given Imaging, Ltd. HeartWare Limited Horizon Therapeutics, Inc.
Human Genome Sciences, Inc. HydroCision, Inc. Idenix
Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. ImmunoGen, Inc.
Incyte Corporation Indevus Pharmaceuticals, Inc. Insulet
Corporation Integra LifeSciences Holdings Corporation InterMune,
Inc. Inverness Medical Innovations, Inc. Isolagen, Inc. Javelin
Pharmaceuticals, Inc. LeMaitre Vascular, Inc. Micrus Endovascular
Corporation Monogram Biosciences, Inc. Myriad Genetics, Inc.
Neuromed Pharmaceuticals Ltd. Novadaq Technologies Inc. NxStage
Medical, Inc. Orexigen Therapeutics, Inc. Osiris Therapeutics, Inc.
Perrigo Company Pharmasset, Inc. Pharmaxis Ltd. Pharmerica Corp.
Poniard Pharmaceuticals, Inc. Presidio Pharmaceuticals, Inc. PTC
Therapeutics Quality Systems Inc. Rigel Pharmaceuticals, Inc. S*BIO
Pte Ltd. Sangamo BioSciences, Inc. Somaxon Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc. STARLIMS Technologies Ltd. SXC
Health Solutions Corp. Synta Pharmaceuticals Corp. TargeGen, Inc.
Transcept Pharmaceuticals, Inc. Vascular Biogenics Ltd. Vertex
Pharmaceuticals Incorporated ViroPharma Incorporated Vitae
Pharmaceuticals, Inc. XDX, Inc. ZIOPHARM Oncology, Inc. About JMP
Group JMP Group Inc. is a full-service investment banking and asset
management firm that provides investment banking, sales and
trading, and equity research services to corporate and
institutional clients and alternative asset management products to
institutional and high-net-worth investors. JMP Group operates
through two subsidiaries, JMP Securities and JMP Asset Management.
For more information, visit www.jmpg.com.
JMP (NYSE:JMP)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
JMP (NYSE:JMP)
Historical Stock Chart
Von Jul 2023 bis Jul 2024